| Literature DB >> 27251487 |
Brandon Michael Henry1,2, Jens Vikse3,4, Matthew J Graves3,4, Silvia Sanna5, Beatrice Sanna6, Iwona M Tomaszewska7, R Shane Tubbs8, Krzysztof A Tomaszewski3,4.
Abstract
INTRODUCTION: The recurrent laryngeal nerves (RLN) are branches of the vagus nerve that go on to innervate most of the intrinsic muscles of the larynx. Historically, the RLN has been considered to branch after it enters the larynx, but numerous studies have demonstrated that it often branches before. The wide variability of this extralaryngeal branching (ELB) has significant implications for the risk of iatrogenic injury. We aimed to assess the anatomical characteristics of ELB comprehensively.Entities:
Keywords: Anatomic variations; Extralaryngeal branching; Recurrent laryngeal nerve; Surgery; Thyroid
Mesh:
Year: 2016 PMID: 27251487 PMCID: PMC5086344 DOI: 10.1007/s00423-016-1455-7
Source DB: PubMed Journal: Langenbecks Arch Surg ISSN: 1435-2443 Impact factor: 3.445
Search terms and strategy for PubMeb
| 1 | (((“recurrent laryngeal nerve”[Title/Abstract]) OR “nervus laryngeus recurrens”[Title/Abstract]) OR “inferior laryngeal nerve”[Title/Abstract]) OR “inferior thyroid artery”[Title/Abstract] |
| 2 | ((((((“anatomy”[Title/Abstract]) OR “variation”[Title/Abstract]) OR “anomaly”[Title/Abstract]) OR “course”[Title/Abstract]) OR “relationship”[Title/Abstract]) OR “branching”[Title/Abstract]) OR “division”[Title/Abstract] |
| 3 | 1 AND 2 |
| 4 | (“recurrent laryngeal nerve/anatomy and histology”[MeSH Major Topic]) |
| 5 | “non recurrent laryngeal nerve”[Title/Abstract] |
| 6 | “Zuckerkandl’s Tubercle” |
| 7 | “Galen’s anastomosis” OR “Arytenoid plexus” OR “Cricoid anastomosis” OR “Thyroarytenoid anastomosis” OR “cricothyroid anastomosis” OR “human communicating nerve” |
| 8 | 3 OR 4 OR 5 OR 6 OR 7 |
Fig. 1PRISMA flow chart of study identification and inclusion in the meta-analysis
Table of included studies
| Study | Country | Type |
| % of ELB |
|---|---|---|---|---|
| Al-Salihi and Dabbagh [ | Iraq | C | 212 | 25.5 |
| Altorjay et al. [ | Hungary | IP | 1023 | 51.5 |
| Ardito et al. [ | Italy | IP | 2615 | 72.4 |
| Armstrong and Hinton [ | USA | C | 100 | 73.0 |
| Asgharpour et al. [ | Spain | C | 284 | 54.6 |
| Barczyński et al. [ | Poland | IP | 302 | 22.2 |
| Barczyński et al. [ | Poland | IP | 2500 | 24.5 |
| Bargy et al. [ | France | C | 56 | 10.7 |
| Beneragama and Serpell [ | Australia | IP | 213 | 40.4 |
| Bowden [ | Great Britain | C | 54 | 77.8 |
| Cakir et al. [ | Turkey | C | 130 | 58.5 |
| Cernea et al. [ | Brazil | IR | 2154 | 64.5 |
| Chang [ | China | C | 50 | 100 |
| Chen et al. [ | China | C | 90 | 68.9 |
| Chen et al. [ | China | C | 94 | 69.1 |
| Clader et al. [ | USA | C | 50 | 58.0 |
| Dai et al. [ | China | IR | 339 | 59.9 |
| Dilworth [ | England | C | 66 | 100 |
| Fontenot et al. [ | USA | IR | 719 | 36.7 |
| Gurleyik [ | Turkey | IP | 200 | 27.0 |
| Gurleyik [ | Turkey | IP | 185 | 33.0 |
| Hisham and Lukman [ | Malaysia | IP | 490 | 34.1 |
| Hsu et al. [ | China | C | 177 | 100 |
| Iqbal and Zumair [ | Pakistan | IR | 93 | 58.1 |
| Jiang et al. [ | China | IR | 292 | 63.4 |
| Kandil et al. [ | USA | IP | 310 | 42.9 |
| Katz and Nemiroff [ | USA | IP | 1177 | 63.5 |
| Keros and Nemanić [ | Croatia | C | 300 | 100 |
| King and Gregg [ | USA | C | 43 | 27.9 |
| Kulekci et al. [ | Turkey | C | 194 | 80.4 |
| Kuo et al. [ | China | C | 100 | 62.0 |
| Laux and Guerrier [ | France | C | 200 | 43.0 |
| Lu et al. [ | China | C + IR | 66 | 27.3 |
| Makay et al. [ | Turkey | IP | 253 | 24.1 |
| Matubis et al. [ | Philippines | C | 108 | 14.8 |
| Moreau et al. [ | France | C | 34 | 29.4 |
| Morrison [ | USA | C | 200 | 43.0 |
| Nemiroff and Katz [ | USA | IP | 153 | 41.2 |
| Ngo Nyeki et al. [ | Cameroon and Gabon | IP | 62 | 9.7 |
| Nguyen et al. [ | France | C | 60 | 86.7 |
| Norland [ | USA | C | 62 | 96.8 |
| Page et al. [ | France | IP | 403 | 19.4 |
| Pascoal et al. [ | Brazil | C | 44 | 70.5 |
| Pichler and Gisel [ | Austria | C | 100 | 100 |
| Pradeep et al. [ | India | IR | 583 | 30.5 |
| Prior and Fasce [ | Italy | C | 100 | 11.0 |
| Reed [ | USA | C | 506 | 5.3 |
| de Souza 1981 [ | Brazil | C | 98 | 25.5 |
| Rueger [ | USA | C | 19 | 100 |
| Rustad [ | USA | C | 200 | 43.0 |
| Salama and McGrath [ | Australia | C | 144 | 65.3 |
| Schweizer and Dörfl [ | Switzerland | C | 42 | 88.1 |
| Serpell et al. [ | Australia | IP | 838 | 25.7 |
| Serpell [ | Australia | IR | 977 | 24.7 |
| Shao et al. [ | China | IP | 4241 | 8.6 |
| Shao et al. [ | China | IR | 2869 | 11.2 |
| She et al. [ | China | C | 200 | 42.0 |
| She et al. [ | China | C | 100 | 100 |
| Sun et al. [ | China | C | 100 | 94.0 |
| Sunderland and Swaney [ | Australia | C | 130 | 70.0 |
| Tang et al. [ | China | C | 160 | 91.9 |
| Wang et al. [ | China | IR | 63 | 76.2 |
| Weeks and Hinton [ | USA | IR | 17 | 88.2 |
| Williams [ | England | C | 100 | 100 |
| Yalcin et al. [ | Turkey | C | 96 | 92.7 |
| Yalcin et al. [ | Turkey | C | 120 | 93.3 |
| Yang et al. [ | China | C | 90 | 100 |
| Yuan [ | China | C | 117 | 67.5 |
| Zhou et al. [ | China | C | 120 | 100 |
ELB extralaryngeal branching, C cadaveric, IP intraoperative prospective, IR intraoperative retrospective
Fig. 2Forest plot for prevalence of extralaryngeal branching of the recurrent laryngeal nerve
Subgroup analysis for the prevalence of extralaryngeal branching
| Subgroup | No. of studies (no. of nerves) | Pooled prevalence of ELB % (95 % CI) |
|
|---|---|---|---|
| Overall | 69 (28,387) | 60.0 (52.0–67.7) | 99.4 (99.4–99.5) |
| Cadaveric | 42 (5250) | 73.3 (61.0–84.0) | 98.9 (98.8–99.0) |
| Intraoperative | 26 (23,071) | 39.2 (29.0–49.9) | 99.6 (99.6–99.6) |
| Intraoperative (prospective) | 16 (14,965) | 33.4 (20.5–47.7) | 99.7 (99.6–99.7) |
| Intraoperative (retrospective) | 10 (8106) | 50.2 (32.0–68.4) | 99.6 (99.5–99.6) |
| Left sides | 29 (6443) | 56.6 (43.6–69.2) | 98.9 (98.8–99.1) |
| Right sides | 30 (6561) | 58.5 (45.1–71.3) | 99.0 (98.9–99.1) |
| Males | 6 (420) | 59.6 (20.0–87.8) | 97.3 (95.8–98.2) |
| Females | 6 (794) | 59.7 (22.7–92.0) | 98.1 (97.1–98.7) |
| Asia | 23 (10,754) | 66.1 (50.2–80.4) | 99.5 (99.5–99.6) |
| Europe | 24 (9417) | 62.7 (49.2–75.3) | 99.3 (99.2–99.4) |
| North America | 12 (3456) | 55.8 (39.3–71.7) | 98.7 (98.4–99.0) |
| Oceania | 5 (2302) | 44.3 (29.0–60.2) | 97.9 (96.8–98.7) |
| South America | 3 (2296) | 53.4 (25.3–80.5) | 96.7 (93.3–98.4) |
*p value for Cochran’s Q for all subgroups was <0.001
Fig. 3Types of extralaryngeal branching patterns of the recurrent laryngeal nerve with their pooled cadaver prevalence rates. Presented as pooled prevalence rate (95% confidence interval)
Type of branching by type of study
| No. of studies (no. of nerves) | No branching % (95 % CI) | Bifurcation % (95 % CI) | Trifurcation % (95 % CI) | Multiple branches % (95 % CI) |
| |
|---|---|---|---|---|---|---|
| Overall | 47 (16,618) | 42.0 (28.1–47.1) | 51.1 (35.7–55.3) | 4.7 (1.0–9.2) | 2.2 (0–5.9) | 99.3 (99.2–99.4) |
| Cadaveric | 27 (3361) | 23.4 (7.1–36.9) | 61.1 (33.8–78.4) | 9.0 (0.3–20.9) | 6.5 (0–15.5) | 99.1 (99.0–99.2) |
| Intraoperative | 19 (13,191) | 61.3 (49.1–72.4) | 37.6 (26.2–49.4) | 1.0 (0–4.1) | 0.1 (0–1.7) | 99.4 (99.3–99.5) |
| Intraoperative (prospective) | 12 (6644) | 65.4 (52.0–77.5) | 33.2 (21.2–46.4) | 1.2 (0–5.0) | 0.1 (0–2.0) | 99.0 (98.8–99.2) |
| Intraoperative (retrospective) | 8 (6613) | 56.8 (35.5–75.9) | 42.1 (22.3–62.4) | 0.7 (0–6.2) | 0.4 (0–5.1) | 99.5 (99.4–99.6) |
*p value for Cochran’s Q for all subgroups was <0.001
Type of branching by side, gender, and geographical origin
| No. of studies (no. of nerves) | No branching % (95 % CI) | Bifurcation % (95 % CI) | Trifurcation % (95 % CI) | Multiple branches % (95 % CI) |
| |
|---|---|---|---|---|---|---|
| Overall | 47 (16,618) | 42.0 (28.1–47.1) | 51.1 (35.7–55.3) | 4.7 (1.0–9.2) | 2.2 (0–5.9) | 99.3 (99.2–99.4) |
| Left sides | 26 (3942) | 50.7 (33.2–60.6) | 38.9 (23.2–49.6) | 6.3 (0.7–14.2) | 4.1 (0–9.8) | 98.5 (98.2–98.7) |
| Right sides | 26 (4262) | 45.5 (28.0–56.3) | 43.4 (26.2–54.3) | 6.8 (0.8–15.4) | 4.3 (0–10.5) | 98.7 (98.5–98.9) |
| Males | 5 (362) | 39.8 (4.5–70.7) | 46.8 (8.0–76.2) | 9.0 (0–31.8) | 4.3 (0–23.0) | 97.5 (96.1–98.5) |
| Females | 5 (754) | 39.6 (0–76.6) | 49.1 (3.6–85.6) | 6.2 (0–33.2) | 5.1 (0–30.8) | 98.4 (97.6–98.9) |
| Asia | 19 (5849) | 35.2 (13.1–49.4) | 49.9 (23.1–62.2) | 8.1 (0–18.6) | 6.8 (0–16.6) | 99.4 (99.4–99.5) |
| Europe | 16 (5624) | 35.7 (18.6–48.4) | 59.0 (38.0–69.6) | 3.8 (0–10.5) | 1.5 (0–6.3) | 99.1 (98.9–99.2) |
| North America | 7 (2007) | 53.0 (31.3–71.8) | 43.4 (22.8–62.9) | 2.6 (0–10.9) | 1.0 (0–7.1) | 98.6 (98.1–99.0) |
| Oceania | 3 (1195) | 57.7 (33.5–79.2) | 37.0 (15.7–60.3) | 5.3 (0–17.9) | 0.1 (0–4.4) | 97.7 (95.7–98.8) |
*p value for Cochran’s Q for all subgroups was <0.001
Distance from the extralaryngeal branching site to the inferior rim of the cricothyroid joint
| Distance (cm) | Pooled prevalence % (95 % CI) |
|---|---|
| 0–1 | 15.4 (0–37.3) |
| 1–2 | 74.8 (44.7–94.1) |
| 2–3 | 6.0 (0–22.2) |
| 3–4 | 3.8 (0–17.7) |
Six studies (456 nerves with ELB), I 2 = 97.1 % (95 % CI 95.4–98.1), p < 0.001
Motor signaling in extralaryngeal branches of the recurrent laryngeal nerve
| Study ID | Method of signal detection |
| Positive motor signal in anterior branch (%) | Positive motor signal in posterior branch (%) |
|---|---|---|---|---|
| Barczyński et al. [ | NIM 2.0 followed by the NIM 3.0 system (Medtronic USA, Inc., Jacksonville, FL) at 1 mA | 613 | 613 (100 %) | 8 (1.3 %) |
| Gurleyik [ | IONM device. Nerve Integrity Monitor (NIM-Response 3.0 System; Medtronic Xomed, Jacksonville, FL) at 1 mA | 61 | 61 (100 %) | 7 (11.5 %) |
| Fontenot et al. [ | IONM device (Xomed NIM System; Medtronic USA, Inc., Jacksonville, FL) at 1.0 mA | 264 | 264 (100 %) | 3 (1.1 %) |
| Kandil et al. [ | IONM device (Xomed NIM System; Medtronic USA, Inc., Jacksonville, FL) at 0.5 mA | 133 | 133 (100 %) | 0 (0 %) |
| Serpell et al. [ | IONM device (Xomed NIM System; Medtronic USA, Inc., Jacksonville, FL) | 41 | 41 (100 %) | 0 (0 %) |